Anti-Nucleoporin p62/NUP62 antibody [EPR9919]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(6 Publications)
Rabbit Recombinant Monoclonal Nucleoporin p62/NUP62 antibody. Suitable for WB and reacts with Human samples. Cited in 6 publications.
View Alternative Names
Nuclear pore glycoprotein p62, 62 kDa nucleoporin, Nucleoporin Nup62, NUP62
- WB
Unknown
Western blot - Anti-Nucleoporin p62/NUP62 antibody [EPR9919] (AB140651)
All lanes:
Western blot - Anti-Nucleoporin p62/NUP62 antibody [EPR9919] (ab140651) at 1/10000 dilution
Lane 1:
HepG2 cell lysates at 10 µg
Lane 2:
Raji cell lysates at 10 µg
Secondary
All lanes:
HRP conjugated goat anti-rabbit at 1/2000 dilution
Predicted band size: 53 kDa
false
Related conjugates and formulations (1)
-
Anti-Nucleoporin p62/NUP62 antibody [EPR9919] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
NUP62 is essential for maintaining the normal function of the nuclear pore complex. It forms a soluble subcomplex with other nucleoporins facilitating nuclear pore assembly. This protein contributes to the dynamic nature of the nuclear porins ensuring efficient and selective transport. NUP62 also interacts directly with nucleic acids and other transport receptors allowing for the precise regulation of nuclear-cytoplasmic exchange processes.
Pathways
NUP62 takes part in critical transport pathways such as the karyopherin-mediated import and export processes. It collaborates with importin-beta a transport receptor that binds to nuclear localization signals on cargo proteins. Through these pathways NUP62 ensures that essential proteins and RNAs are correctly swapped between the nucleus and the rest of the cell playing an important role in cellular homeostasis and gene expression regulation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
International journal of oral science 17:34 PubMed40246825
2025
Applications
Unspecified application
Species
Unspecified reactive species
The international journal of neuropsychopharmacology 27: PubMed39099166
2024
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10:e2302677 PubMed37387563
2023
Applications
Unspecified application
Species
Unspecified reactive species
Food science & nutrition 11:1965-1981 PubMed37051356
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy. Nucleic acids 30:30-47 PubMed36189423
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 13:4051-4062 PubMed35129051
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com